Filed: 8/14/2024ACC: 0001104659-24-089335
📋 What this filing means
AVORO CAPITAL ADVISORS LLC filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $7.51B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$7.51B
Total AUM (reported)
206.62M
Total Shares
Allocation by class
COMMON$5.94B79.2%
SPONSORED ADR$1.16B15.5%
ETF$281.37M3.7%
CLASS A ORD$121.80M1.6%
Portfolio Concentration
Top 3$2.06B27.4%
4–10$2.84B37.9%
11–25$2.18B29.0%
Rest$429.23M5.7%
Top 3 weight
27.4%
Top 10 weight
65.3%
Voting Authority Distribution
Total shares with voting rights: 206.62M
Sole
Full voting authority
206.62M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole41
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings41
Rows:
UNITED THERAPEUTICS CORP
SOLEShares2.86M
TypeSH
Market value$910.70M
12.13%
Sole
2.86M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares2.06M
TypeSH
Market value$575.88M
7.67%
Sole
2.06M
Shared
0.00
None
0.00
ASCENDIS PHARMA
SOLEShares4.20M
TypeSH
Market value$572.34M
7.62%
Sole
4.20M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares1.24M
TypeSH
Market value$532.59M
7.09%
Sole
1.24M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares3M
TypeSH
Market value$474.00M
6.31%
Sole
3M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares2.43M
TypeSH
Market value$446.80M
5.95%
Sole
2.43M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC.
SOLEShares11.11M
TypeSH
Market value$426.22M
5.68%
Sole
11.11M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares4.56M
TypeSH
Market value$375.21M
5.00%
Sole
4.56M
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG
SOLEShares7.54M
TypeSH
Market value$308.29M
4.11%
Sole
7.54M
Shared
0.00
None
0.00
SPDR SERIES TRUST - S&P BIOTECH
SOLEShares3.04M
TypeSH
Market value$281.37M
3.75%
Sole
3.04M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC.
SOLEShares27.40M
TypeSH
Market value$271.81M
3.62%
Sole
27.40M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares6.50M
TypeSH
Market value$265.73M
3.54%
Sole
6.50M
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS INC.
SOLEShares8.89M
TypeSH
Market value$231.02M
3.08%
Sole
8.89M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares5.67M
TypeSH
Market value$220.94M
2.94%
Sole
5.67M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares3M
TypeSH
Market value$205.47M
2.74%
Sole
3M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares4.31M
TypeSH
Market value$155.92M
2.08%
Sole
4.31M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares2.77M
TypeSH
Market value$121.80M
1.62%
Sole
2.77M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares3.89M
TypeSH
Market value$116.08M
1.55%
Sole
3.89M
Shared
0.00
None
0.00
ALNYLAM PHARMCEUTICALS INC.
SOLEShares400K
TypeSH
Market value$97.20M
1.29%
Sole
400K
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares11.70M
TypeSH
Market value$93.83M
1.25%
Sole
11.70M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares2.09M
TypeSH
Market value$85.34M
1.14%
Sole
2.09M
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.35M
TypeSH
Market value$80.18M
1.07%
Sole
1.35M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares3.89M
TypeSH
Market value$79.83M
1.06%
Sole
3.89M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares12.57M
TypeSH
Market value$77.68M
1.03%
Sole
12.57M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares3.54M
TypeSH
Market value$72.92M
0.97%
Sole
3.54M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
UNITED THERAPEUTICS CORPSOLE | Common | 2.86M | SH | $910.70M 12.13% | 2.86M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | Common | 2.06M | SH | $575.88M 7.67% | 2.06M | 0.00 | 0.00 |
ASCENDIS PHARMASOLE | Sponsored ADR | 4.20M | SH | $572.34M 7.62% | 4.20M | 0.00 | 0.00 |
ARGENX SESOLE | Sponsored ADR | 1.24M | SH | $532.59M 7.09% | 1.24M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | Common | 3M | SH | $474.00M 6.31% | 3M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | Common | 2.43M | SH | $446.80M 5.95% | 2.43M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INC.SOLE | Common | 11.11M | SH | $426.22M 5.68% | 11.11M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | Common | 4.56M | SH | $375.21M 5.00% | 4.56M | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNGSOLE | Common | 7.54M | SH | $308.29M 4.11% | 7.54M | 0.00 | 0.00 |
SPDR SERIES TRUST - S&P BIOTECHSOLE | ETF | 3.04M | SH | $281.37M 3.75% | 3.04M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INC.SOLE | Common | 27.40M | SH | $271.81M 3.62% | 27.40M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | Common | 6.50M | SH | $265.73M 3.54% | 6.50M | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INC.SOLE | Common | 8.89M | SH | $231.02M 3.08% | 8.89M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | Common | 5.67M | SH | $220.94M 2.94% | 5.67M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | Common | 3M | SH | $205.47M 2.74% | 3M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | Common | 4.31M | SH | $155.92M 2.08% | 4.31M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 2.77M | SH | $121.80M 1.62% | 2.77M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | Common | 3.89M | SH | $116.08M 1.55% | 3.89M | 0.00 | 0.00 |
ALNYLAM PHARMCEUTICALS INC.SOLE | Common | 400K | SH | $97.20M 1.29% | 400K | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | Common | 11.70M | SH | $93.83M 1.25% | 11.70M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | Common | 2.09M | SH | $85.34M 1.14% | 2.09M | 0.00 | 0.00 |
MERUS N VSOLE | Common | 1.35M | SH | $80.18M 1.07% | 1.35M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | Common | 3.89M | SH | $79.83M 1.06% | 3.89M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | Common | 12.57M | SH | $77.68M 1.03% | 12.57M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | Common | 3.54M | SH | $72.92M 0.97% | 3.54M | 0.00 | 0.00 |
Page 1 of 2